SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-036408
Filing Date
2024-03-26
Accepted
2024-03-26 16:10:36
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K annx-20231231.htm   iXBRL 10-K 3050891
2 EX-23.1 annx-ex23_1.htm EX-23.1 3302
3 EX-31.1 annx-ex31_1.htm EX-31.1 16803
4 EX-31.2 annx-ex31_2.htm EX-31.2 16825
5 EX-32.1 annx-ex32_1.htm EX-32.1 14934
6 EX-97.1 annx-ex97_1.htm EX-97.1 42113
7 GRAPHIC img135382036_0.jpg GRAPHIC 84241
8 GRAPHIC img135382036_1.jpg GRAPHIC 29242
9 GRAPHIC img135382036_2.jpg GRAPHIC 29828
10 GRAPHIC img135382036_3.jpg GRAPHIC 30115
11 GRAPHIC img135382036_4.jpg GRAPHIC 227278
  Complete submission text file 0000950170-24-036408.txt   10237184

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT annx-20231231.xsd EX-101.SCH 1247720
76 EXTRACTED XBRL INSTANCE DOCUMENT annx-20231231_htm.xml XML 1263954
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39402 | Film No.: 24783620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)